The Fort Worth Press - Brazil approves world's first single-dose dengue vaccine

USD -
AED 3.672504
AFN 64.000368
ALL 80.878301
AMD 368.276037
ANG 1.789884
AOA 918.000367
ARS 1398.655759
AUD 1.37836
AWG 1.8025
AZN 1.70397
BAM 1.65809
BBD 2.008732
BDT 122.377178
BGN 1.668102
BHD 0.376584
BIF 2968.504938
BMD 1
BND 1.264635
BOB 6.891611
BRL 4.915095
BSD 0.997329
BTN 94.180832
BWP 13.389852
BYN 2.818448
BYR 19600
BZD 2.00585
CAD 1.36715
CDF 2265.000362
CHF 0.776955
CLF 0.022646
CLP 890.873638
CNY 6.80075
CNH 6.796265
COP 3727.014539
CRC 458.479929
CUC 1
CUP 26.5
CVE 93.480565
CZK 20.636704
DJF 177.601628
DKK 6.340404
DOP 59.310754
DZD 132.326735
EGP 52.744691
ERN 15
ETB 155.726591
EUR 0.84804
FJD 2.18304
FKP 0.733657
GBP 0.73346
GEL 2.67504
GGP 0.733657
GHS 11.234793
GIP 0.733657
GMD 73.503851
GNF 8750.794795
GTQ 7.614768
GYD 208.672799
HKD 7.83165
HNL 26.513501
HRK 6.393304
HTG 130.575219
HUF 300.190388
IDR 17377.45
ILS 2.901304
IMP 0.733657
INR 94.425504
IQD 1306.515196
IRR 1311500.000352
ISK 122.010386
JEP 0.733657
JMD 157.187063
JOD 0.70904
JPY 156.678504
KES 128.803357
KGS 87.420504
KHR 4001.526006
KMF 418.00035
KPW 899.999743
KRW 1461.920383
KWD 0.30766
KYD 0.831164
KZT 460.946971
LAK 21871.900301
LBP 89311.771438
LKR 321.097029
LRD 183.01047
LSL 16.361918
LTL 2.95274
LVL 0.60489
LYD 6.306642
MAD 9.121445
MDL 17.054809
MGA 4165.995507
MKD 52.257217
MMK 2099.442981
MNT 3580.105345
MOP 8.041456
MRU 39.863507
MUR 46.820378
MVR 15.403739
MWK 1729.049214
MXN 17.177604
MYR 3.921039
MZN 63.910377
NAD 16.361918
NGN 1365.000344
NIO 36.700437
NOK 9.209304
NPR 150.68967
NZD 1.675884
OMR 0.384681
PAB 0.997329
PEN 3.448264
PGK 4.404222
PHP 60.515038
PKR 277.958713
PLN 3.59545
PYG 6092.153787
QAR 3.645458
RON 4.426304
RSD 99.504048
RUB 74.240007
RWF 1462.082998
SAR 3.767486
SBD 8.019432
SCR 14.874401
SDG 600.503676
SEK 9.215704
SGD 1.267404
SHP 0.746601
SLE 24.650371
SLL 20969.496166
SOS 569.963122
SRD 37.399038
STD 20697.981008
STN 20.770633
SVC 8.727057
SYP 110.581023
SZL 16.351151
THB 32.203038
TJS 9.305159
TMT 3.5
TND 2.896867
TOP 2.40776
TRY 45.347504
TTD 6.759357
TWD 31.316038
TZS 2598.109449
UAH 43.809334
UGX 3737.018354
UYU 39.777881
UZS 12097.83392
VES 499.23597
VND 26308
VUV 117.263765
WST 2.707097
XAF 556.107838
XAG 0.012445
XAU 0.000212
XCD 2.70255
XCG 1.797465
XDR 0.69162
XOF 556.107838
XPF 101.106354
YER 238.625037
ZAR 16.38071
ZMK 9001.203584
ZMW 18.98775
ZWL 321.999592
  • RBGPF

    0.7000

    63.61

    +1.1%

  • RYCEF

    -0.4100

    16.37

    -2.5%

  • CMSD

    0.1140

    23.534

    +0.48%

  • BTI

    0.2000

    58.28

    +0.34%

  • GSK

    -0.0900

    50.41

    -0.18%

  • RELX

    0.0759

    33.58

    +0.23%

  • RIO

    2.2700

    105.38

    +2.15%

  • BCE

    -0.4300

    24.14

    -1.78%

  • NGG

    0.9800

    86.89

    +1.13%

  • CMSC

    0.1400

    23.11

    +0.61%

  • JRI

    0.0000

    13.15

    0%

  • VOD

    0.5100

    16.2

    +3.15%

  • BP

    -0.4700

    43.34

    -1.08%

  • BCC

    -2.0900

    70.67

    -2.96%

  • AZN

    0.3300

    182.85

    +0.18%

Brazil approves world's first single-dose dengue vaccine
Brazil approves world's first single-dose dengue vaccine / Photo: © AFP

Brazil approves world's first single-dose dengue vaccine

Brazilian authorities on Wednesday approved the world's first single-dose dengue vaccine, which they hailed as a "historic" achievement as cases of the mosquito-borne disease soar globally due to rising temperatures.

Text size:

Dengue, known for intense flu-like symptoms, crushing fatigue and body aches, reached record global levels in 2024 and researchers have attributed its spread to climate change.

Brazil's health regulatory agency ANVISA authorized the use of Butantan-DV, developed by the Butantan Institute in São Paulo, for people aged 12 to 59.

Currently, the only dengue vaccine available worldwide is TAK-003, which requires two doses administered three months apart, according to the World Health Organization (WHO).

The single dose, developed after eight years of trials across Brazil, will allow for faster and simpler vaccination campaigns.

"This is a historic achievement for science and health in Brazil," Esper Kallas, director of the Butantan Institute, a public research center, told a press conference in Sao Paulo.

"A disease that has plagued us for decades can now be fought with a very powerful weapon," he added.

The new vaccine showed 91.6 percent efficacy against severe dengue during the clinical trials which involved more than 16,000 volunteers.

Dengue's unpleasant symptoms have earned it the nickname "breakbone fever." It can provoke hemorrhagic fever in severe cases, and death.

It is transmitted by infected Aedes mosquitoes, which have expanded beyond their usual areas, leading to dengue cases in Europe or parts of the United States where they were not typically found.

Globally, the WHO reported more than 14.6 million cases and almost 12,000 deaths in 2024, the highest number ever recorded.

Half of these deaths took place in Brazil.

Researchers at Stanford University in the United States published a study in 2024 estimating that global warming was responsible for 19 percent of dengue cases that year.

Brazil has reached an agreement with the Chinese company WuXi Biologics to deliver approximately 30 million doses of the vaccine in the second half of 2026, Health Minister Alexandre Padilha told the press conference.

M.Cunningham--TFWP